Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.
about
CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severityCharacterization of human cytochrome P450 enzymes catalyzing domperidone N-dealkylation and hydroxylation in vitroHow to calculate the dose of chemotherapyPharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapyCYP3A4 and CYP3A5 genotyping by PyrosequencingSirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular EffectsMaraviroc: a review of its use in HIV infection and beyondRole of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in ChildrenGenetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic reviewPharmacogenomics of adverse drug reactionsPrevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerationsPharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision MedicineVincristine-induced peripheral neuropathy in pediatric cancer patientsMechanism-based inactivation of CYP450 enzymes: a case study of lapatinibPharmacogenomics and personalized medicine: a review focused on their application in the Chinese populationInfluence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipientsPolymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemiaPharmacogenetics of erectile dysfunction: navigating into uncharted watersFunctionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping testsSequence diversity and haplotype structure at the human CYP3A clusterInfluence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patientsLess efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans.Causes of genome instability: the effect of low dose chemical exposures in modern societyPharmacogenomic discovery using cell-based modelsDrug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metaboliteNewly identified CYP2C93 is a functional enzyme in rhesus monkey, but not in cynomolgus monkeyFunctional evaluation of genetic and environmental regulators of p450 mRNA levelsLiver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in TanzaniaGenome-wide discovery of drug-dependent human liver regulatory elementsFinasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialInteraction between Darunavir and Etravirine Is Partly Mediated by CYP3A5 PolymorphismGenetic variability in CYP3A5 and its possible consequences.Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes.Gene conversion causing human inherited disease: evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair.Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma.Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylationConcordant gene expression in leukemia cells and normal leukocytes is associated with germline cis-SNPsThe Nod2 gene in Crohn's disease: implications for future research into the genetics and immunology of Crohn's disease.CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation.A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state
P2860
Q21261465-301505CE-8F7C-4EEF-9C2D-926EC99635FAQ24301858-E07C3402-4AA9-4530-BA50-93E419FC72EBQ24642872-8B1C9EDF-C9B4-48FF-B594-D1EEF19C937EQ24676890-21375C88-C978-4FEA-A473-A8330FAF5095Q24810187-762A00F6-FB0C-4445-9E72-7B0D18B1086BQ26749011-5D346B00-578E-4C44-BF92-716D95CAEAD8Q26778504-6139449D-1893-48EC-B873-A8C910AC7980Q26798470-3D3CA042-0EA8-45BA-97D4-3132AEDD1C46Q26823434-941EC7AD-6D44-453B-92EB-98F032EC8EDBQ27015820-34CE9BC4-547A-40F6-BA9C-0B46DAD83B7DQ27024142-3E8B3BBE-4ABB-4D46-AE3D-40FAF4D80F1BQ27692687-596BA75D-8193-46CA-8D1F-CE9156F71BE2Q28078232-72687B12-C24F-453E-B185-048CD8C0E782Q28080497-355E5B5A-F706-4093-9E0E-3460369B3A8BQ28083875-35742CE4-0502-415D-AD51-3A2D516B5CCFQ28244228-EB1C44CD-6661-4FD3-9836-098E7CC16D5AQ28245060-1DCD502C-ACFF-4C4E-977A-FDD9B8C7C361Q28249515-4DDA41F9-7A6E-4AD9-8973-AD1B9E88467EQ28260518-C4BC1AC4-B103-455A-894D-9D4BC5FFE9D6Q28284189-B58DC23D-58C3-42A2-BE17-5E905F6CEB71Q28293875-A5733BFD-6C61-4BC6-B24A-64B8BBF553A1Q28387774-C62CBB12-CFD9-48BC-9D48-975E40BF9B2FQ28388277-2A7D793A-C197-4A73-83D0-9BB813EF54D4Q28392982-97FCE1E6-A080-4FEB-B47E-61C84C76B14DQ28472957-E1AE5BB8-C4D2-475A-BA45-FC407419EC58Q28477100-20881898-A5E2-47BB-867E-D0E722FB2B23Q28477350-330FD33F-F8CA-440B-B56F-19DBEA107917Q28481272-DF1DD761-4C1B-49D6-A26C-5681A3173225Q28543477-F8E9C4AF-A928-44FA-8C3D-29E97A39CC31Q28547130-9D20F47E-0ACF-4B07-959D-1856D4776536Q28552997-7C116DE6-98A5-4CE2-B7AE-174496CF451BQ30341330-77A0D649-8364-4771-9B3F-F1284CC4D111Q30357429-DD96FEA2-81CA-4CB0-A2E6-75B53B6ECBA7Q30491768-64EFAC85-10FB-4534-856B-2CDCDDD6E1D1Q30532640-7670B1AF-7142-40E9-8DAF-7420164970A9Q33251030-6FC084D5-A30C-40DF-B590-2A7B464EB71AQ33334373-C2973110-2A78-4E4E-8605-94FFEC52C758Q33335841-317561A9-C962-47E1-AB92-85B9A95E7BD7Q33368192-1F9F1A11-BBE3-47D6-8B41-FDA3DA2920DBQ33390197-7926B099-07D0-4BC2-AB14-D4D18E6286CE
P2860
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Sequence diversity in CYP3A pr ...... polymorphic CYP3A5 expression.
@en
Sequence diversity in CYP3A pr ...... polymorphic CYP3A5 expression.
@nl
type
label
Sequence diversity in CYP3A pr ...... polymorphic CYP3A5 expression.
@en
Sequence diversity in CYP3A pr ...... polymorphic CYP3A5 expression.
@nl
prefLabel
Sequence diversity in CYP3A pr ...... polymorphic CYP3A5 expression.
@en
Sequence diversity in CYP3A pr ...... polymorphic CYP3A5 expression.
@nl
P2093
P356
P1433
P1476
Sequence diversity in CYP3A pr ...... polymorphic CYP3A5 expression.
@en
P2093
Boguski MS
P2888
P304
P356
10.1038/86882
P407
P50
P577
2001-04-01T00:00:00Z